You are here: vision-research.eu » Vision Research » Vision in the European Focus

Vision in the European Focus

Mireca signs transformative deal with Nasdaq-listed Graybug Vision

Mireca’s proprietary cyclic guanosine monophosphate (cGMP) analogues to be developed using Graybug’s sustained-release drug delivery technologies. The partnership is exclusive for the development of products targeting eye and ear disorders. Mireca will invest proceeds to develop the cGMP analogues...
» Mireca signs transformative deal with Nasdaq-listed Graybug Vision

The algebra of neurons

Neurons are constantly performing complex calculations to process sensory information and infer the state of the environment. For example, to localize a sound or to recognize the direction of visual motion, individual neurons are thought to multiply two signals. However, how such a computation is...
» The algebra of neurons

Understanding human vision through Deep Learning

By adapting techniques from the domain of artificial intelligence, such as deep learning, cognitive scientists from Osnabrück will study the core principles of human vision over the next five years. Professor Dr. Tim Kietzmann, who specializes in neuro-inspired Machine Learning, has been awarded the...
» Understanding human vision through Deep Learning

More than light detectors: The magic of your eyes' pupils

The mechanisms we use to sense quantity are located in our pupils. This is the result of a study conducted by the School of Psychology of the University of Sydney, in collaboration with the Universities of Pisa and Florence (Italy), recently published in Nature Communications.
» More than light detectors: The magic of your eyes' pupils

Researchers discover new type of nerve cell in the retina

Scientists at the John A. Moran Eye Center at the University of Utah have discovered a new type of nerve cell, or neuron, in the retina.
» Researchers discover new type of nerve cell in the retina

Medical technology: diabetes retinal screening through deep learning

Diabetic retinopathy (DR), a complication of the retina brought about by diabetes, is one of the most frequent reasons for vision loss in European adults between 25 and 60 years of age. When detected early, treatment can effectively reduce or prevent vision loss. To date however, national screening...
» Medical technology: diabetes retinal screening through deep learning

Giving sight back to the blind, an increasingly realistic scenario

Created by the Institut de la Vision, the bioelectronics start-up Pixium Vision - the originator of the new generation of retinal prostheses - is joining forces with Second Sight, an innovative Californian company, to form the world leader in vision restoration, of which it will be the majority...
» Giving sight back to the blind, an increasingly realistic scenario

Science Summit 2021 - Falling Walls Science Summit 7–9 Nov 2021

The Science Breakthroughs of the Year 2021
» Science Summit 2021 - Falling Walls Science Summit 7–9 Nov 2021

Bird pupils behave unexpectedly different

The pupil not only regulates the amount of light entering the eye, but also reflects the state of the brain: when we are aroused or focused, the pupils dilate. The pupil even changes as mammals sleep, constricting during deep non-REM sleep and dilating in REM sleep. Now, for the first time,...
» Bird pupils behave unexpectedly different

"Time is Retina": If the eye suddenly sees nothing anymore, there is no time to lose.

Ocular infarction is a medical emergency - study investigates early restoration of blood flow in acute infarction
»  "Time is Retina": If the eye suddenly sees nothing anymore, there is no time to lose.